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a  b  s  t  r  a  c  t
Takayasu’s arteritis (TA) and rheumatic fever are diseases that can start with cardiac fea-
tures, making the diagnosis difﬁcult. There are reports of association of RF with Takayasu’s
arteritis beginning with cardiac involvement in pediatric patients. The aim of this study is
to  report the possible association of RF and TA in patients with cardiac abnormalities. We
describe the case of an adolescent initially diagnosed with RF who progressed with changes
that allowed making the diagnosis of TA. TA and RF are two important causes of valve
involvement that may have systemic manifestations.
© 2014 Elsevier Editora Ltda. All rights reserved.
Associac¸ão  entre  febre  reumática  e  arterite  de  Takayasu  –  Relato  de  caso
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Manifestac¸ões cardíacas
r  e  s  u  m  o
A arterite de Takayasu (AT) e a febre reumática (FR) são doenc¸as que podem ter início com
manifestac¸ão cardíaca, o que diﬁculta o diagnóstico. Há relatos de associac¸ão de FR com
AT  que se inicia com comprometimento cardíaco na faixa etária pediátrica. O objetivo deste
estudo é relatar a possibilidade da associac¸ão de FR e AT em paciente com alterac¸ão cardíaca.Descrevemos o caso de uma adolescente diagnosticada inicialmente como FR que apresen-
tou  na evoluc¸ão alterac¸ões que permitiram o diagnóstico de AT. A AT e a FR são duas causas
importantes de envolvimento valvular que podem apresentar manifestac¸ões sistêmicas.
© 2014 Elsevier Editora Ltda. Todos os direitos reservados.∗ Corresponding author.
E-mail: carolls@uol.com.br (M.C. Santos).
http://dx.doi.org/10.1016/j.rbre.2014.09.003
2255-5021/© 2014 Elsevier Editora Ltda. All rights reserved.
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The aortic valve involvement is the most common, sec-r e v b r a s r e u m a t o l
ntroduction
akayasu’s arteritis (TA) is a chronic granulomatous inﬂam-
atory disease that can affect the aorta, its branches and
ulmonary artery.1,2
In children, it affects women at a ratio of 2:1, similarly to
hat found in a Brazilian multicentric study of 71 children and
dolescents (2.6:1).3 Mean age of onset is 11.4 years, with 20%
efore 19 years and 2% before 10 years of age.4
The initial manifestations may be insidious and non-
peciﬁc, such as asthenia, headache, fever, night sweats,
rthralgia, muscle pain and weight loss, starting at variable
imes before vascular disease, or may be acute with high blood
ressure, seizures and congestive heart failure.5
Cardiac impairment occurs in about 50% of patients in
he course of the disease, and any cardiac structure can be
ffected. When presented with valve regurgitation, the patient
ay initially be diagnosed with rheumatic fever.
We reported a case of TA in an adolescent with cardiac valve
mpairment with early diagnosis of rheumatic fever.
ase  report
 15-year-old adolescent, female, white, was admitted with
 history of palpitations associated with adynamia and 7-kg
eight loss, 10 months ago. On physical examination, the
atient was pale, tachycardic, and afebrile with blood pressure
BP) of 130 × 70 mmHg  (90-percentile). On cardiac auscultation,
oud P2 and systolic murmur in mitral area radiating to the
ack present symmetrical pulses.
Laboratory tests showed anemia, with mild leukocytosis
nd thrombocytosis, elevated inﬂammatory activity and titra-
ion of anti-streptolysin O antibody (ASLO) (Table 1).
Chest radiography showed cardiac area at the upper limit,
he echocardiogram showed moderate left ventricular dilata-
ion with thickening of the mitral valve and mitral (mild) and
ortic (mild to moderate) regurgitation, with an ejection frac-
ion of 51%, and inﬂammation on myocardium scintigraphy.
ith these data, she was diagnosed with rheumatic fever
RF). Treatment with prednisone, digoxin, and hydrochloroth-
azide was initiated, with prophylaxis with benzathine
enicillin, with normalization of inﬂammatory activity. In out-
atient follow-up, corticosteroids were gradually reduced and
Table 1 – Progress of laboratory alterations.
Hospital
admission
12 days after the
use of PRED
Postsuspension
of  PRED
Hemoglobin 9.04 12.8 11.6 
Leucocytes 13,000 24,000 
Platelets 635,000 523,000 630,000 
ESR/CRP 120/7.8 5 37/19.5 
Alpha-1-acid glycoprotein 195 188 246 
ASLO 1379 1560 – 
PPD – – – 
Creatinine/serum urea – – –  6;5 6(2):178–180 179
discontinued after three months of its initiation, maintaining
adequate secondary prophylaxis.
After discontinuation of corticosteroids, she showed exer-
tional dyspnea, tachycardia, lower limb edema, auscultation
of epigastric murmurs and increased blood pressure. On labo-
ratory investigation, inﬂammatory activity tests were high and
PPD was negative. Echocardiography revealed normal mitral
valve and mild aortic regurgitation and an ejection fraction
of 63%. Chest tomography detected parietal thickening of the
aorta and its branches, and presence of dilation (2.6 cm)  in
the thoracoabdominal transition that is suggestive of arteri-
tis. The hypothesis of TA was conﬁrmed by the changes
evidenced in arteriography. (Fig. 1) Methotrexate and pred-
nisone were associated with clinical and laboratory control of
inﬂammation.
Currently, the patient is being followed on diagnosis of TA
and RF, with prednisone, methotrexate, folic acid, digoxin,
anti-hypertensives and prophylaxis with benzathine peni-
cillin.
Discussion
TA is uncommon, especially in the pediatric population,
although it is a major cause of renovascular hypertension.
Genetic factors and infectious and immunological pro-
cesses are described in etiopathogenesis.
In the case described, as Jones criteria were met, it allowed
the diagnosis of RF, but the nonspeciﬁc manifestations that
preceded FR symptoms suggest the presence of a systemic
inﬂammatory vasculitis of insidious onset.6 In the course of
the disease, the presence of epigastric murmur, hypertension
and abnormal angiography allowed the diagnosis of TA based
on the revised criteria EULAR/PReS.7 The association of RF and
TA is uncommon.8 Tejada et al.9 reported 2 cases of rheumatic
heart disease in a series of 125 patients with TA. At our service,
within 11 cases of TA, only this patient had heart changes
consistent with RF.
Cardiac involvement occurs in up to 50% of patients with
TA, and may impair any heart structure.10,11 Coronary arteri-
tis, heart valve lesion, and ventricular aneurysm are the main
manifestations reported in children with TA.18  days after
reintroduction of
PRED
3 months after
PRED
6 months after
PRED
Current
14.6 11.5 11.5
12,600 5300 19,230
543,000 530,000 444,000
20/<0.3 40/4.4 26 18/<0.4
– 129 125 –
– 129 125 –
– – Negative –
– – 0.5/14 –
ondary to aortitis with annular dilation or inﬂammatory valve
retraction.10 There are reports of involvement of mitral and
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tricuspid valves in approximately 20% of TA patients, often
with regurgitation, with no evidence of valve thickening.11 In
autopsy studies, there are reports of aortic valve thickening
secondary to arteritis of the aorta extending to valve and mural
endocardium.12
The presence of mitral valve thickening, associated with
streptococcus, with resolution after treatment with cortico-
steroids does not allow ruling out TA-associated RF. According
to Vale et al.13, the combination of RF and TA raises the possi-
bility of a common immunologic basis in the pathogenesis of
both disorders.
TA and RF are two major causes of valve involvement, the
presence of systemic manifestations, echocardiographic and
arteriographic ﬁndings are helpful in the diagnosis of cardiac
involvement.
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